Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Palovarotene Action Against Heterotopic Ossification Includes a Reduction of Local Participating Activin A‐Expressing Cell Populations

JBMR Plus(2023)10.1002/jbm4.10821Source: DataRank Database

Palovarotene Action Against Heterotopic Ossification Includes a Reduction of Local Participating Activin A‐Expressing Cell Populations is a research paper published in JBMR Plus (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 1.70)OA: goldTopics (13)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Lutian Yao ORCID,Kelly A. Shaughnessy,Cheri Saunders ORCID,Eileen M. Shore ORCID,Eiki Koyama ORCID

Live enrichment

PubMed:38130748 PMC:PMC10731142 OpenAlex:https://openalex.org/W4387820389

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: R01AR071946

FWCI

1.70

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jbm4.10821

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jbm4.10821

journalhttps://doi.org/10.1002/jbm4.10821

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38130748

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10731142

Fields of Study

Heterotopic Ossification and Related ConditionsGenetic Syndromes and ImprintingKruppel-like factors research

Keywords

Heterotopic ossificationReduction (mathematics)MedicineAnatomyendochondral ossificationActivin AProgenitor CellsFibrodysplasia Ossificans ProgressivaRetinoid AgonistsPalovarotene

Sustainable Development Goals

SDG 0: Good health and well-being

Palovarotene Action Against Heterotopic Ossification Includes a Reduction of Local Participating Activin A‐Expressing Cell Populations

FAIR Checklist

Authors (7)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)